Form 8-K Amphastar Pharmaceutical For: May 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amphastar Pharma (AMPH) Tops Q1 EPS by 15c
May 9, 2016 4:40 PM EDTAmphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.12, $0.15 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $59.4 million versus the consensus estimate of $62 million.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
... More


